Partner Headlines - SLXP

  1. Will Activis Win Competition For Allergan's Affection?

    Benzinga
  2. AbbVie Board To Shareholders: Vote No On Shire Buy

    IBD
  3. Shire Falls, AbbVie Questioned On Buyout Backtrack

    IBD
  4. Stocks Dive, Then Pare Losses; Shire, Expedia, KeyCorp Crumble

    IBD
  5. IBD 50: Medical, Internet Companies Top Q3 Estimates

    IBD
  6. Patents, Taxes Lift Drug M&A

    IBD
  7. IBD 50: Medical, Internet Companies Top Q3 Profit Estimates

    IBD
  8. Drugmaker M&A Goes On, With Or Without Tax Inversions

    IBD
  9. Allergan Steeply Raises Guidance, Taunts Valeant

    IBD
  10. Salix, Actavis Among Big Cap Pharmas In Merger Mambo

    IBD
  11. Salix Pharmaceuticals

    IBD
  12. Actavis Finds Rx To Grow On Busy Drugmaker M&A Scene

    IBD
  13. Progenics Receives $40M Milestone Following FDA Approval of RELISTOR ...

    Benzinga
  14. Stocks Further Deteriorate; Salix Breaks Support

    IBD
  15. Gilead Among Top IBD 50 Stocks Heading Into Earnings

    IBD
  16. Salix Bails On Tax Inversion

    IBD
  17. Nasdaq, S&P 500 Aim For 50-Day Lines; Alexion Breaks Out

    IBD
  18. Salix Cancels Tax Inversion, Opens Way For Buyers

    IBD
  19. Stocks Open Higher On Jobs Data; Mylan, Salix, Mobileye Climb

    IBD
  20. Jobs Data Boost Stock Futures; Salix, Tekmira, Iamgold Rising

    IBD
  21. SALIX PHARMACEUTICALS

    IBD
  22. Top Fund Buys: Chipotle, Allergan, Jazz, Gilead

    IBD
  23. Stifel Raises Price Target On Salix Pharmaceuticals, Ltd. On ...

    Benzinga
  24. Morning Market Losers

    Benzinga
  25. Large-Cap Tech, Biotech Names Hang Tough In Shaky Market

    IBD
  26. Stocks Fade More In Late Trade; GoPro Hangs Tough

    IBD
  27. Rebound Efforts Fade For Stocks; Synchronoss Clears Resistance

    IBD
  28. Jackson Square Partners Joins Investors Opposing Allergan Bid ...

    Benzinga
  29. Facebook Among 5 IBD 50 Stocks Holding Near Highs

    IBD
  30. Meet 5 Top Stocks With Rising Earnings Estimates

    IBD
  31. Valeant: Glaucoma Drug Is Potential Blockbuster

    IBD
  32. Wave Of Selling Hits Stocks; IPO CyberArk Extends Gains

    IBD
  33. Benzinga's M&A Chatter for Wednesday September 24, 2014

    Benzinga
  34. Pharma Buyout Bids Beat On

    IBD
  35. Facebook, Three Other Leaders In Striking Distance

    IBD
  36. Valeant Ends Prince Charming Act; Allergan Hopes Rise

    IBD
  37. #PreMarket Primer: Wednesday, September 24: US Economy Looking ...

    Benzinga
  38. Ackman forewarns Allergan

    IBD
  39. Benzinga's M&A Chatter for Tuesday September 23, 2014

    Benzinga
  40. Stocks Finish Lower Among Takeover Rumors

    IBD
  41. Dow Down 0.6%; CarMax Shares Fall After Q2 Results

    Benzinga
  42. Stocks Fall To Session Lows; Vipshop Bucks The Trend

    IBD
  43. Ascena Retail Drops On Downbeat Earnings; CF Industries Shares ...

    Benzinga
  44. Stocks Fall Modestly; New Issue Alibaba Extends Losses

    IBD
  45. Allergan-Ackman Flame War Reignites On Salix Rumors

    IBD
  46. Markets Mixed; Carnival Profit Tops Street View

    Benzinga
  47. Indexes Pare Losses As Salix Soars On Buyout Talk

    IBD
  48. Benzinga's Volume Movers

    Benzinga
  49. Stocks Hitting 52-Week Highs

    Benzinga
  50. Morning Market Movers

    Benzinga
  51. Stock Futures Lower, But Salix Soars On Buyout Talk

    IBD
  52. Benzinga's Top #PreMarket Gainers

    Benzinga
  53. #PreMarket Primer: Tuesday, September 23: First Airstrikes In ...

    Benzinga
  54. US Stock Futures Fall Ahead Of Economic Data

    Benzinga
  55. Stocks To Watch For September 23, 2014

    Benzinga
  56. Salix Pharmaceuticals, Ltd. Set To Be Acquired By Allergan, Inc.

    Benzinga
  57. Benzinga's M&A Chatter for Monday September 22, 2014

    Benzinga
  58. IBD 50 Stocks Setting Up, Including These 5 Medicals

    IBD
  59. Salix Secures Additional Intellectual Property Relating To Rifaximin

    Benzinga
  60. Stocks Erase Modest Gains; Netflix Gaps Below 50-Day Line

    IBD
  61. Valeant, Allergan Settle Suit, Allow Shareholder Vote

    IBD
  62. UCERIS 2mg Rectal Foam For The Induction Of Remission Of Mild-To-Moderate ...

    Benzinga
  63. Nasdaq Sinks As Tesla, Other Highfliers Get Hit

    IBD
  64. Gilead, Jazz, Salix Among Top 6 IBD 50 Drugmakers

    IBD
  65. Credit Suisse Sees Downside In Shares Of Salix Pharmaceuticals, ...

    Benzinga
  66. Stocks Drag Lower Despite Data; Conversant Soars On ADS Buyout

    IBD
  67. Four Stock Spotlight Names Near Buy Points

    IBD
  68. IBD 50 Showing Little Distress, But Few Big Winners

    IBD
  69. Salix, Gilead Among 5 Top Medical Leaders To Watch

    IBD
  70. Gilead, Jazz Among 4 Top Big Cap Medicals To Watch

    IBD
  71. After Big Run, Does Chip Designer NXP Have More Left?

    IBD
  72. S&P 500 Marks New High As Indexes Hold Gains

    IBD
  73. SALIX PHARMACEUTICALS

    IBD
  74. Major Indexes Turn Mixed; Jazz Pharmaceuticals Turns Up

    IBD
  75. Benzinga's M&A Chatter for Tuesday August 19, 2014

    Benzinga
  76. Salix Soars On Allergan Buzz

    IBD
  77. Indexes Rally On Strong Housing Data, Retail Reports

    IBD
  78. Stocks Add To Gains; Salix Surges On Potential Bid

    IBD
  79. Allergan Reportedly Eyes Salix To Avoid Valeant Deal

    IBD
  80. JP Morgan Says Jazz Pharmaceuticals Positioned For 'Organic Growth ...

    Benzinga
  81. Near Entries: Cavium, Autohome, Skyworks And Facebook

    IBD
  82. US Stock Futures Signal Higher Start On Wall Street

    Benzinga
  83. Leaders Actavis, Salix Trip Sell Signals

    IBD
  84. Easing Tensions Push Stocks Up In Afternoon Trade

    IBD
  85. Stocks Sharply Higher As Russia Ends Maneuvers

    IBD
  86. Stocks Up Despite Airstrikes; Nvidia, Monster, Ubiquiti Soar

    IBD
  87. Salix Sinks In #PreMarket On Disappointing Outlook, Q2 Results

    Benzinga
  88. Sterne Agee Adjusts Estimates For Salix Pharmaceuticals

    Benzinga
  89. Salix Q2 Misses Estimates; Novo Nordisk, Mylan Slide

    IBD
  90. Salix misses, guidance in line

    IBD
  91. Novo Nordisk, Mylan Miss Views; Mallinckrodt Beats

    IBD
  92. Earnings Scheduled For August 7, 2014

    Benzinga
  93. Top Performing Funds Play Favorits

    IBD
  94. Prescription Drugmakers Slide Down Industry Rankings

    IBD
  95. 5 Drug Companies Profiting From Generics

    Benzinga
  96. Salix, Actavis Lead IBD 50 Drug Earnings This Week

    IBD
  97. TAL Education, Team Health Join The IBD 50 Resistance

    IBD
  98. Steven Cohen Has a Track Record of Impressive Returns

    GuruFocus
  99. Tough Sledding For Growth Stocks Amid Market Distribution

    IBD
  100. US Stock Futures Tumble Ahead Of Morgan Stanley Earnings

    Benzinga
Trading Center